We carry an extensive line of high quality serum and reagents to the research community at competitive prices. Our products include Serum (including United States and Australian Fetal Bovine Serum), Serum Enhancers (DMEM and RPMI), Antibiotics, Specialty Media and Customized Applications.

Our full line of proprietary products will consist of LIFOR® and its derivatives, which will be targeted toward different segments of the tissue and organ transplant markets. Based on our experience, we believe that our products will be readily adopted by key decision makers in the research, diagnostic and therapeutic markets.

For whole organ preservation and transplantation we will offer LIFOR® and our proprietary perfusion device. LIFOR® will support the recovery, transportation and reimplantation of kidneys, livers and hearts, as well as connective and other essential therapeutic tissues. Click to view our latest product video!

For living tissue cell preservation and proliferation we offer LIFORCELL® solution. This solution can preserve living cells and is a Fetal Bovine Serum Replacement. Stem Cell studies have shown that LIFORCELL™ can proliferate stem cell the same as FBS. This solution is also an excellent transport and storage solution at room temperature for most cells.

Benefits of LIFOR® and LIFORCELL®

• More Time: Our solution permits significantly longer periods for transporting recovered tissues or organs, thereby increasing the number of tissue samples and whole organs available for use across cities, states and countries and, thus, potentially increasing the size of the market.
• Less Damage: Our solution minimizes damage to cells in transit because it does not require cold temperatures for preservation, unlike all other methods.
• Cell Repair: Our solution helps cells to repair themselves, especially from damage caused during the recovery process so that long term viability - including organ transplants - improves.
• Sterile State: Our solutions do not use any animal sera or proteins, so the risk of infection or contamination is minimized.
• Ubiquity: Our solutions are useful for hypothermic, normothermic, and cryogenic preservation, so that one solution can have multiple applications.

Our technology is fully developed and has recently been trial-marketed to cell media users. Clinical trials are underway to gain the approval of the U.S. Food and Drug Administration for whole organ transplantation. We have patents pending for our solution and for our perfusion device which pumps solution through whole organs.